Innate Pharma S.A. carries a market capitalization of 165.74M, placing it among publicly traded companies globally.
| Market Cap | 165.74M |
| Enterprise Value | N/A |
Innate Pharma S.A.'s stock has declined approximately -6.11702% over the past 52 weeks. The 50-day moving average sits at 1.80, while the 200-day moving average is 1.74.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.11702% |
| 50-Day Moving Average | 1.80 |
| 200-Day Moving Average | 1.74 |
| Average Volume (20 Days) | N/A |